UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063524
Receipt number R000072703
Scientific Title A multicenter study of a smartphone-based web questionnaire for monitoring health status after radiotherapy
Date of disclosure of the study information 2026/11/05
Last modified on 2026/11/05 13:41:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter study of a smartphone-based web questionnaire for monitoring health status after radiotherapy

Acronym

A multicenter study of a smartphone-based web questionnaire for monitoring health status after radiotherapy

Scientific Title

A multicenter study of a smartphone-based web questionnaire for monitoring health status after radiotherapy

Scientific Title:Acronym

A multicenter study of a smartphone-based web questionnaire for monitoring health status after radiotherapy

Region

Japan


Condition

Condition

Breast cancer and prostate cancer

Classification by specialty

Breast surgery Urology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the feasibility of a smartphone-based web questionnaire for monitoring health status during and after radiotherapy, added to usual care with clinician review of responses, using the questionnaire completion rate as the primary outcome.

Basic objectives2

Others

Basic objectives -Others

Feasibility of remote health monitoring using a web questionnaire

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Questionnaire completion rate: the proportion of participants who provide valid responses to at least 60% of questionnaires distributed through 90 days after completion of radiotherapy.

Key secondary outcomes

Usability questionnaire responses, longitudinal changes in symptom severity and health status visual analogue scale, withdrawal, and operational problems including delivery failures, assessed through 90 days after radiotherapy.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

In addition to usual care, participants complete a smartphone-based web questionnaire and clinicians review responses within two working days. Questionnaires are distributed every 7 days during radiotherapy, at completion, and 7, 14, 21, 28, 42, 56 and 90 days after completion.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients aged 18 years or older receiving postoperative radiotherapy for breast cancer or definitive radiotherapy for prostate cancer. The patient or family member can receive email and complete the web questionnaire; an email address accessible to the patient is required, and a family member using their address must attend the clinic. The patient provides electronic informed consent and the treating clinician completes enrollment.

Key exclusion criteria

Patients judged unable to provide informed decisions because of cognitive impairment, unable to continue responding because of poor general condition, or otherwise unsuitable as judged by the investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Keiichi
Middle name
Last name Jingu

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Radiation Oncology

Zip code

980-8574

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

022-717-7312

Email

keiichi.jingu.e8@tohoku.ac.jp


Public contact

Name of contact person

1st name Kazuya
Middle name
Last name Takeda

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Radiation Oncology

Zip code

980-8574

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

022-717-7312

Homepage URL


Email

kazuya.takeda.a8@tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Japanese Society for Radiation Oncology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi

Tel

022-728-4105

Email

ec-med@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院(宮城県)、東北医科薬科大学病院(宮城県)、みやぎ県南中核病院(宮城県)


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD

Undecided. Any future use or sharing for research will require ethics review and appropriate consent or notification and an opportunity to opt out.

IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 07 Day

Date of IRB

2026 Year 11 Month 04 Day

Anticipated trial start date

2026 Year 11 Month 16 Day

Last follow-up date

2027 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 05 Day

Last modified on

2026 Year 11 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072703